Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
University of Washington
University of Washington
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
Emory University
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Mayo Clinic
University of Southern California
Mayo Clinic
M.D. Anderson Cancer Center
Mayo Clinic
Mayo Clinic
Emory University
Mayo Clinic
City of Hope Medical Center
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
Academic and Community Cancer Research United
Mayo Clinic
Emory University
Sun Yat-sen University
Ohio State University Comprehensive Cancer Center
University of California, San Francisco
Mayo Clinic
Mayo Clinic
Mayo Clinic
University of Southern California
Wuerzburg University Hospital
Academic and Community Cancer Research United
Universitätsklinikum Hamburg-Eppendorf
University of Washington
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
Mayo Clinic
Mayo Clinic
University of Arkansas
PETHEMA Foundation
OHSU Knight Cancer Institute
Boston Medical Center
Boston Medical Center
Barbara Ann Karmanos Cancer Institute